Athenex Inc

Most Recent

  • uploads///ATNX
    Company & Industry Overviews

    How’s Athenex’s Financial Performance?

    In fiscal 2017, Athenex (ATNX) generated total revenues of $38 million—compared to $20.5 million in fiscal 2016.

    By Kenneth Smith
  • uploads///ATNX
    Company & Industry Overviews

    Athenex’s Product Groups and Geographic Performance

    The majority of Athenex’s revenues in Q1 2018 came from API sales, commercial product sales, and license fees.

    By Kenneth Smith
  • uploads///ATNX
    Company & Industry Overviews

    Analyzing Athenex’s Cash Flows

    In fiscal 2017, Athenex (ATNX) incurred interest expenses of $5.9 million—compared to $1.8 million in fiscal 2016.

    By Kenneth Smith
  • uploads///ATNX
    Company & Industry Overviews

    A Focus on Pipeline Expansion Bodes Well for Athenex

    Athenex announced a strategic investment of $100 million from Perceptive Advisors.

    By Kenneth Smith
  • uploads///ATNX
    Company & Industry Overviews

    How Athenex’s Business Segments Performed in Q1 2018

    Athenex (ATNX) operates in three business segments—Oncology Innovative Platform, Global Supply Chain Platform, and Commercial Platform.

    By Kenneth Smith
  • uploads///ATNX
    Company & Industry Overviews

    Understanding Athenex’s Research Platforms

    Athenex’s (ATNX) Orascovery platform is based on the P-gp pump inhibitor molecule, HM30181A. Athenex licensed the molecule from Hanmi.

    By Kenneth Smith
  • uploads///pills _
    Company & Industry Overviews

    Analysts’ Ratings for Athenex and Its Peers in March

    Of the six analysts covering Athenex in March 2018, five analysts gave the stock a “buy” rating, while one analyst gave it a “hold” rating.

    By Kenneth Smith
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.